https://www.selleckchem.com/pr....oducts/dt-061-smap.h
The rates of freedom from re-operation and actuarial mitral valve survival rates at 5, 10, and 15 years were 99%, 95%, and 93% and 96%, 91%, and 89%, respectively, in group A, and 96%, 91%, and 91% and95%, 94%, and 94% in group S. The long-term surgical outcomes of MVr using both techniques were feasible. Over the long-term, the ePTFE rupture rate of CV-5 was higher than that of CV-4. The long-term surgical outcomes of MVr using both techniques were feasible. Over the long-term, the ePTFE rupture rate of CV-5 was higher than that of